Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...

GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy ...

In the December quarter, the company's management said it plans to double the firm's pen capacity over the next couple of ...

John Cena makes history in his heavyweight match against Cody Rhodes, Paul Heyman was the x-factor in the triple threat match ...

People with type 2 diabetes taking the highest dose of Eli Lilly’s experimental drug orfoglipron lowered their blood sugar and lost 16 pounds on average after 40 weeks.

Americans spent an estimated $71.7 billion on GLP-1 drugs including Ozempic and Wegovy in 2023, a 500 percent increase from ...

Pharmaceutical giant Eli Lilly (LLY) surged 14% last week to $840 per share following positive Phase 3 trial results for its ...

Orforglipron, a once-daily glucagon-like peptide-1 (GLP-1) receptor agonist, significantly reduced hemoglobin A1c (HbA1c) in adults with type 2 diabetes (T2D) and inadequate glycemic control with diet ...

Trends and Innovations webinar will provide insight into the rising use of GLP-1 drugs by consumer and its effect on the food and beverage industry.

Dr. Bharti Shetye, also known as Dr. Abby, CEO and Physician Owner of Dr. Abby’s Weight Management Clinic, recently joined Gayle Guyardo, host of the global health and ...

Novo Nordisk remains an industry leader, and currently offers both a 2.7% dividend yield and compelling value that can work ...

Medicaid plans often put up barriers around newer classes of diabetes medications that offer cardioprotection, according to a ...